Indokem Ltd

NSE: BSE: 504092

₹496

(1.22%)

Mon, 06 Jul 2026, 10:26 pm

MTF 5xInvest in Indokem Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)1377.26

PE Ratio734.81

Dividend0

Process Industries

Industrial Specialties

24.5K

Indokem News

Indokem closes trading window ahead of Q1FY26 results

Indokem Limited has closed its trading window for designated persons from July 1, 2026, until 48 hours after Q1FY26 results are declared.

22 Jun 2026

companies

Indokem Posts FY26 Standalone Profit of ₹213 Lakhs

Indokem's Board approves FY26 audited results; standalone profit rises to ₹213 lakhs vs ₹92 lakhs in FY25. Key leadership reappointments also approved at the May 4, 2026 meeting.

04 May 2026

companies

Indokem Board Meet on May 4 for Q4FY26 Results

Indokem Limited schedules board meeting on May 4, 2026, to consider audited standalone and consolidated financial results for Q4 and FY26. Trading window closed from April 1.

27 Apr 2026

companies

Indokem Promoters Hold 68.67% Stake as of March 2026

Indokem Limited's promoters and promoter group entities collectively hold 1,91,50,083 equity shares representing 68.67% stake as of March 31, 2026, with no new encumbrances reported during FY26.

04 Apr 2026

companies

Indokem Q3FY26 Results: Profit Jumps to ₹86 Lakhs

Indokem Limited reports strong Q3FY26 performance with standalone profit of ₹86 lakhs vs ₹12 lakhs last year. Nine-month profit reaches ₹185 lakhs, reversing previous year's loss of ₹240 lakhs.

30 Jan 2026

co actions results

Showing 1–5 of 12

Rows per page:

Market Current News

SEBI Approves Rentomojo Ltd's IPO

SEBI has granted approval for Rentomojo Ltd's Initial Public Offering, marking a key regulatory milestone for the company's planned market debut.

06 Jul 2026

ipo

Concord Biotech Limited

Concord Biotech to hold 41st AGM on July 31

Concord Biotech Limited has scheduled its 41st Annual General Meeting for July 31, 2026, via video conferencing. The company has received a notice proposing the appointment of Mrs. Ekta Gupta as a Director.

06 Jul 2026

ipo

GUJARAT KIDNEY AND SUPER SPECI

Gujarat Kidney approves IPO proceeds variation

Shareholders approved the variation in the objects and terms of utilisation of the IPO proceeds. The resolution received 99.9995% votes in favour.

06 Jul 2026

ipo

SEBI Approves Manipal Health Enterprises IPO

SEBI has granted approval for Manipal Health Enterprises to proceed with its initial public offering, marking a significant milestone for the healthcare company.

06 Jul 2026

ipo

NSE Seeks RBI Nod for Quanto Cross Currency Derivatives

NSE has requested RBI approval to introduce Quanto Cross Currency Derivatives, aiming to boost exchange-traded currency volumes in India.

06 Jul 2026

currency

Showing 1–5 of 93967

Rows per page: